PubMed HealthSearch

Biomedical subjects

N Ohtsuki

Publications and source records attributed to N Ohtsuki.

10 recordsLinked to original sources

Bilateral multiple renal adenocarcinomas in a patient with acquired renal cystic disease: correlation of imaging with pathological study.

The findings of computed tomography (CT), magnetic resonance imaging (MRI), and angiography were correlated with the histopathological findings in a patient with acquired renal cystic disease (ARCD) and bilateral multiple renal adenocarcinomas. Hemodialysis patients, especially with ARCD, should have a follow-up imaging study for an early detection of renal adenocarcinomas because multiple renal adenocarcinomas would arise frequently and simultaneously from ARCD.

Carcinoma, Renal Cell

[The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].

Blood ammonia and serum free carnitine were measured in 49 severely handicapped epileptic patients treated with or without valproate. DL- or L-carnitine were administered to patients treated with valproate, and the effects of carnitine supplementation were evaluated. Furthermore we analyzed the relationship between serum free carnitine and nutrition. In patients treated with valproate, blood ammonia statistically increased, and serum free carnitine concentration statistically decreased. Free carnitine was low in tube-fed patients, as compared with that in oral-fed patients. Carnitine therapy was successful in improvement of hyperammonemia and hypocarnitinemia. It is concluded that hypocarnitinemia was caused not only by valproate therapy, but also by tube-feeding. Carnitine supplementation therapy is important to both hyperammonemia and hypocarnitinemia. But the long term effect of carnitine therapy remains to be studied further.

Adolescent

Decrease in human growth hormone (HGH) levels during transsphenoidal surgery for acromegaly as a guide for prognosis.

To evaluate the clinical significance of human growth hormone (HGH) dynamics during transsphenoidal microsurgery for acromegaly, serial HGH levels during the surgery were compared with the post-operative basal HGH levels in 15 acromegalic patients, retrospectively. In all patients, in whom the HGH level immediately after tumor resection was reduced below 5 ng/ml or the decreasing rate which stood for the magnitude of decrease of HGH during resection procedure was above 80%, postoperative permanent HGH levels fell to below 5 ng/ml, namely, within the normal range. The rapid radioimmunoassay (RIA) of HGH was developed by the use of high affinity antibody in order to inform the surgeons of plasma HGH levels quickly during the surgery. It is now possible to know HGH levels about 1 hour after submitting the samples. It was verified that HGH levels measured in the rapid RIA correlated well with those obtained in the conventional way. The rapid RIA method was applied to 6 patients and the correlation between HGH levels during the surgery and post operative levels was also studied prospectively. The results were essentially identical to those in a retrospective study. It was suggested that the HGH level immediately after tumor resection and the extent of the decrease in HGH during the resection procedure were good indicators of the prognosis of surgical results in acromegaly and the rapid RIA method was useful in order to judge HGH levels quickly during the surgery.

Acromegaly

Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats.

To evaluate the hypotensive effect and pharmacokinetic properties of some metabolites of hydralazine (HP), blood pressure and plasma concentrations after the i.v. or i.p. administration of HP pyruvate, alpha-ketoglutarate and acetone hydrazones and 3-methyl-s-triazolo[3,4a]phthalazine were estimated in normotensive rats, in addition to in vitro kinetic studies of the formation and decomposition. All the hydrazones studied had an effective hypotensive effect after a high dosing (10 mg/kg); however, their potency was much smaller than that of HP, when plasma-free concentration-response curves were compared. 3-methyl-s-triazolo[3,4a]phthalazine had no hypotensive effect at the same dose. Virtually no effective quantities of HP were generated in plasma after i.v. injection of these hydrazones (10 mg/kg) except for HP acetone hydrazone although a specific and sensitive analytical method for HP was used. The metabolites had larger elimination rate constants and smaller apparent distribution volumes than those of HP. Hydrazones in vitro were formed according to a second-order rate kinetics from HP and various keto acids or ketone at pH 7.4 and 37 degrees C, and these compounds were partly decomposed under the same conditions. Of the metabolites HP pyruvic acid hydrazone was the most readily formed and relatively stable hydrazone, whereas HP acetone hydrazone was unstable. The present results indicate that the contribution of the hydrazones to the vasodepressor properties of HP is only partial or negligible and that the hypotensive effect after dosing of HP is related mainly to its free concentration.

Animals

Clinical evaluation of free thyroxine calculation from thyroxine and thyroxine binding globulin radioimmunoassays.

Free T4 calculation was performed based on the equation of the law of mass action between T4 and TBG assessed by routine radioimmunoassay. To examine the validity of this calculation, sera from normal subjects, from hypo- and hyperthyroid patients, from subjects with hereditary deficiency or increase in TBG, and those from uncomplicated pregnancy were included in the assay and the results were compared with those directly measured by radioimmunoassay with encapsulated antibody. Free T4 calculation on the sera described above was almost equal to the free T4 concentration measured directly and reflected clinical thyroid states. Thus, the proposed equation for the calculation of free T4 from total T4 and TBG radioimmunoassay is useful for clinical purposes as well as direct free T4 radioimmunoassay.

Female

Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.

TSH receptor binding-inhibiting (TBI) and thyroid-stimulating (TSI) activities of Graves' immunoglobulin Gs (IgGs) were measured using the murine TSH receptor (mTBI) and the McKenzie LATS bioassay. In contrast to the expectation that only the IgGs positive for LATS showed mTBI activity, mTBI activity was closely correlated with TBI activity measured at the human TSH receptor regardless of LATS potency (r = 0.79; P less than 0.01), indicating a lack of species specificity of IgG in this particular aspect. In 7 to 15 IgGs positive for both mTBI and LATS, there was a significant correlation between the 2 parameters (r = -0.89; P less than 0.01). However, 4 IgGs among the 15 were positive for mTBI but negative for LATS even when tested at 3- to 7-fold concentrations of IgG.

Animals